Cargando…
Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors
Glyoxalase-I (Glo-I) enzyme was established to be a valid target for anticancer drug design. It performs the essential detoxification step of harmful byproducts, especially methylglyoxal. A robust computer-aided drug design approach was used to design and validate a series of compounds with selenium...
Autores principales: | Al-Balas, Qosay A., Al-Smadi, Mousa L., Hassan, Mohammad A., Al Jabal, Ghazi A., Almaaytah, Ammar M., Alzoubi, Karem H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766947/ https://www.ncbi.nlm.nih.gov/pubmed/31487813 http://dx.doi.org/10.3390/molecules24183210 |
Ejemplares similares
-
Synthesis, antimicrobial and in vitro antitumor activities of a series of 1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives
por: Mhaidat, Nizar M, et al.
Publicado: (2015) -
New Multi-1,2,3-Selenadiazole Aromatic Derivatives
por: Al-Smadi, Mousa, et al.
Publicado: (2005) -
Synthesis, Characterization and Antimicrobial Activity of New 1,2,3-Selenadiazoles
por: Al-Smadi, Mousa, et al.
Publicado: (2008) -
Synthesis, Characterization, Antimicrobial Activity, and Genotoxicity Assessment of Two Heterocyclic Compounds Containing 1,2,3-Selena- or 1,2,3-Thiadiazole Rings
por: Al-Smadi, Mousa L., et al.
Publicado: (2019) -
Generation of the First Structure-Based Pharmacophore Model Containing a Selective “Zinc Binding Group” Feature to Identify Potential Glyoxalase-1 Inhibitors
por: Al-Balas, Qosay, et al.
Publicado: (2012)